文献速递肾小球疾病

靶向APRIL治疗肾小球疾病

Targeting APRIL in the treatment of glomerular diseases.
PubMed 文献 · Kidney Int · 2024-09-07

本文综述了增殖诱导配体(APRIL)在B细胞存活、增殖和免疫球蛋白类别转换中的核心作用及其与肾小球疾病的关系。作者指出,治疗性抑制APRIL是一种有吸引力的免疫调节策略,可在保留记忆B细胞功能和疫苗应答等体液免疫重要功能的同时,消除自身免疫病中的有害宿主免疫反应,与B细胞清除策略不同。文章重点介绍了APRIL抑制剂在IgA肾病中的临床试验数据,该领域临床开发最为深入。

要点

  • APRIL是TNF超家族关键细胞因子,调控B细胞存活、增殖和Ig类别转换。
  • 抑制APRIL可能保留记忆B细胞和疫苗应答,不同于B细胞清除策略。
  • APRIL抑制剂在IgA肾病中临床开发最为深入,已有新兴临床试验数据。

核心结论

  • 治疗性抑制APRIL是肾小球疾病潜在的免疫调节策略,可在消除有害免疫反应的同时保留部分体液免疫功能。

研究设计与样本

  • 本文为综述,描述APRIL在B细胞发育中的生理作用及其与肾小球疾病的相关性,并概述研究APRIL抑制的新兴临床试验数据。

主要发现

  • APRIL是TNF超家族细胞因子的关键成员,在B细胞存活、增殖和Ig类别转换中发挥核心作用。
  • APRIL及相关细胞因子B细胞激活因子在多种肾小球疾病中的作用受到越来越多关注。
  • 与B细胞清除策略不同,抑制APRIL可能保留记忆B细胞功能和疫苗接种应答等体液免疫重要功能。

临床怎么用

  • APRIL抑制剂在IgA肾病中的临床开发最为深入,临床可关注该领域新兴临床试验数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A proliferation-inducing ligand (APRIL) is a key member of the tumor necrosis factor superfamily of cytokines and plays a central role in B-cell survival, proliferation, and Ig class switching. Recently, there has been increasing interest in the role of APRIL and the related cytokine B-cell activating factor in several glomerular diseases, because of their importance in the above processes. The therapeutic inhibition of APRIL represents a potentially attractive immunomodulatory approach that may abrogate deleterious host immune responses in autoimmune diseases while leaving other important functions of humoral immunity intact, such as memory B-cell function and responses to vaccination, in contrast to B-cell-depleting strategies. In this review, we describe the physiological roles of APRIL in B-cell development and their relevance to glomerular diseases, and outline emerging clinical trial data studying APRIL inhibition, with a focus on IgA nephropathy where the clinical development of APRIL inhibitors is in its most advanced stage.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Cheung CK, Barratt J, Lafayette R, et al. Targeting APRIL in the treatment of glomerular diseases. Kidney Int. 2024. PMID: 39182759. doi:10.1016/j.kint.2024.08.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。